Medical companies unite to develop cartilage regeneration productsRSS Feed

A business deal looks set to further the development of cartilage regeneration aimed at spinal injury patients.

Arrowhead's Nanotope Inc, a California-based medical research organisation, has made a deal with Smith & Nephew to advance cartilage regeneration products which could lead to new therapies for spinal cord injury patients.

Smith & Nephew, which specialises in orthopaedics and sports medicine, plans to conduct the preclinical trials and assume all associated costs as well as to market the product.

Nanotope is developing products to regenerate specific tissues including neuronal, vascular, bone and myocardial, and could gain $26.6 million (£16.8 million) from this, according to Arrowhead.

Mark Augusti, President of Smith & Nephew's Biologics and Spine Business unit, said: "We are always searching for alliances with businesses whose technologies address the major unmet needs of our market. Cartilage repair is a clear area of interest to us and we are very pleased to be partnering with Nanotope in this area."

This news comes after reports this week of the first ever stem cell treatment for spinal injury, giving hope to sufferers of the condition.

Serious Law, award winning spinal injury law firm

Posted by Paul Breen
 

Pioneering stem cell research could help spinal injury patients

18 October 2010

A major breakthrough in human embryonic stem cell research has been made by a team of scientists in Singapore.The scientists studied the 21,000 genes in the human body to find the two characteristics important...

Read More...

Hope for spinal injury patients

18 October 2010

A spinal injury patient has become the first person to be treated with human embryonic stem cells, using a process that could potentially allow paralysed individuals to regain some movement.The groundbreaking...

Read More...

Spinal injury patients receive technology grant

15 October 2010

A grant to advance technology which will assist spinal injury patients has been given to a team at Arizona State University and the Children's Neuroscience Institute at Phoenix Children's Hospital.The...

Read More...